Biospectal Announces Public Beta Launch Of OptiBP™ For Android At CES 2021
Summary
Backed by grants from the Bill & Melinda Gates Foundation, Grand Challenges Canada and Innosuisse, Biospectal OptiBP empowers people worldwide with a medical-grade device that integrates directly into the ubiquitous smartphone already in their pocket, enabling instantaneous blood pressure measurement and monitoring, anytime and anywhere. People need an easy to use, digital means to accurately measure, monitor, track and share their blood pressure data with their doctors; a need that the onset of COVID-19 and demand for telehealth solutions has only amplified. The Biospectal OptiBP app runs on a typical smartphone and uses the built-in camera to record and measure a user’s blood flow via their fingertip quickly and easily. Additionally, the captured blood pressure data connects seamlessly with a user’s clinicians to support treatment regimens that help improve health, longevity and quality of life. “For the billions of people living in remote, rural communities, having access to accurate blood pressure readings will enable early diagnosis and hopefully, treatment — preventing illness and loss of life.” Biospectal trained its software algorithm using over two million resulting invasively acquired blood pressure samples recorded in the operating room of the CHUV in partnership with the Swiss Center for Electronics and Microtechnology (CSEM), and then validated it with outpatients in the hypertension clinic CHUV.
Classifications
AskAI Classifications
LabelsLinked Companies
